Intestinal inflammation and cancer

Gastroenterology

Volumn 140, Issue 6, 2011, Pages 1807-1816.e1

  Ullman, Thomas A ^a   Itzkowitz, Steven H ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Adaptive Immunity; Animal Model; IBD; Innate Immunity; Intestine; Neoplasia

Indexed keywords

DNA BASE; MERCAPTOPURINE; MESALAZINE; METHYLPREDNISOLONE; METRONIDAZOLE; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; SALAZOSULFAPYRIDINE; STEROID; TRANSCRIPTION FACTOR; URSODEOXYCHOLIC ACID;

ADAPTIVE IMMUNITY; ARTICLE; CANCER RISK; CARCINOGENESIS; CHROMOSOMAL INSTABILITY; COLON MUCOSA; COLORECTAL CANCER; CROHN DISEASE; DNA METHYLATION; DRUG FATALITY; DRUG MEGADOSE; ENTERITIS; EXCISION REPAIR; HISTOPATHOLOGY; HUMAN; IMMUNE RESPONSE; INNATE IMMUNITY; INTESTINE FLORA; LIVER CIRRHOSIS; LOW DRUG DOSE; MICROSATELLITE INSTABILITY; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; ULCERATIVE COLITIS;

EID: 79955564023     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2011.01.057     Document Type: Article

References (87)

1. F.A. Farraye, R.D. Odze, and J. Eaden AGA technical review on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease Gastroenterology 138 2010 746 774
2. S.H. Itzkowitz, and X. Yio Inflammation and cancer IV Colorectal cancer in inflammatory bowel disease: the role of inflammation Am J Physiol Gastrointest Liver Physiol 287 2004 G7 G17
3. J. Eaden, K. Abrams, and A. Ekbom Colorectal cancer prevention in ulcerative colitis: a case-control study Aliment Pharmacol Ther 14 2000 145 153 (Pubitemid 30088290)
4. D. Pinczowski, A. Ekbom, and J. Baron Risk factors for colorectal cancer in patients with ulcerative colitis: a case-control study Gastroenterology 107 1994 117 120 (Pubitemid 24195353)
5. M. Rutter, B. Saunders, and K. Wilkinson Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis Gastroenterology 126 2004 451 459 (Pubitemid 38182302)
6. R.B. Gupta, N. Harpaz, and S. Itzkowitz Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: a cohort study Gastroenterology 133 2007 1099 1105 (Pubitemid 47494461)
7. C. Mathy, K. Schneider, and Y.Y. Chen Gross versus microscopic pancolitis and the occurrence of neoplasia in ulcerative colitis Inflamm Bowel Dis 9 2003 351 355 (Pubitemid 37461445)
8. F.S. Velayos, J.P. Terdiman, and J.M. Walsh Effect of 5-aminosalicylate use on colorectal cancer and dysplasia risk: a systematic review and metaanalysis of observational studies Am J Gastroenterol 100 2005 1345 1353 (Pubitemid 40904360)
9. T. Ullman, V. Croog, and N. Harpaz Progression to colorectal neoplasia in ulcerative colitis: effect of mesalamine Clin Gastroenterol Hepatol 6 2008 1225 1230
10. S.M. McKenzie, W.F. Doe, and G.D. Buffinton 5-aminosalicylic acid prevents oxidant mediated damage of glyceraldehyde-3-phosphate dehydrogenase in colon epithelial cells Gut 44 1999 180 185 (Pubitemid 29119360)
11. P.J. Bus, I.D. Nagtegaal, and H.W. Verspaget Mesalazine-induced apoptosis of colorectal cancer: on the verge of a new chemopreventive era? Aliment Pharmacol Ther 13 1999 1397 1402 (Pubitemid 29516250)
12. J.B. Brown, G. Lee, and E. Managlia Mesalamine inhibits epithelial b-catenin activation in chronic ulcerative colitis Gastroenterology 138 2010 595 605
13. A. Lyakhovich, and C. Gasche Systematic review: molecular chemoprevention of colorectal malignancy by mesalazine Aliment Pharmacol Ther 31 2010 202 209
14. S. Matula, V. Croog, and S. Itzkowitz Chemoprevention of colorectal neoplasia in ulcerative colitis: the effect of 6-mercaptopurine Clin Gastroenterol Hepatol 3 2005 1015 1021 (Pubitemid 41415750)
15. D.S. Pardi, E.V. Loftus Jr, and W.K. Kremers Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis Gastroenterology 124 2003 889 893 (Pubitemid 36389790)
16. T. Ikegami, Y. Matsuzaki, and J. Shoda The chemopreventive role of ursodeoxycholic acid in azoxymethane-treated rats: suppressive effects on enhanced group II phospholipase A2 expression in colonic tissue Cancer Lett 134 1998 129 139 (Pubitemid 29070729)
17. K.D. Lindor, K.V. Kowdley, and V.A. Luketic High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis Hepatology 50 2009 808 814
18. C.E. Rubin, R.C. Haggitt, and G.C. Burmer DNA aneuploidy in colonic biopsies predicts future development of dysplasia in ulcerative colitis Gastroenterology 103 1992 1611 1620
19. S.H. Itzkowitz Molecular biology of dysplasia and cancer in inflammatory bowel disease Gastroenterol Clin North Am 35 2006 553 571 (Pubitemid 44307575)
20. R.F. Willenbucher, D.E. Aust, and C.G. Chang Genomic instability is an early event during the progression pathway of ulcerative-colitis-related neoplasia Am J Pathol 154 1999 1825 1830 (Pubitemid 29262864)
21. D.E. Aust, J.P. Terdiman, and R.F. Willenbucher The APC/beta-catenin pathway in ulcerative colitis-related colorectal carcinomas: a mutational analysis Cancer 94 2002 1421 1427 (Pubitemid 34212635)
22. M.S. Redston, N. Papadopoulos, and C. Caldas Common occurrence of APC and K-ras gene mutations in the spectrum of colitis-associated neoplasias Gastroenterology 108 1995 383 392
23. L. Tarmin, J. Yin, and N. Harpaz Adenomatous polyposis coli gene mutations in ulcerative colitis-associated dysplasias and cancers versus sporadic colon neoplasms Cancer Res 55 1995 2035 2038
24. N. Umetani, S. Sasaki, and T. Watanabe Genetic alterations in ulcerative colitis-associated neoplasia focusing on APC, K-ras gene and microsatellite instability Jpn J Cancer Res 90 1999 1081 1087
25. G.C. Burmer, P.S. Rabinovitch, and R.C. Haggitt Neoplastic progression in ulcerative colitis: histology, DNA content, and loss of a p53 allele Gastroenterology 103 1992 1602 1610
26. J. Yin, N. Harpaz, and Y. Tong p53 point mutations in dysplastic and cancerous ulcerative colitis lesions Gastroenterology 104 1993 1633 1639 (Pubitemid 23235452)
27. T.A. Brentnall, D.A. Crispin, and P.S. Rabinovitch Mutations in the p53 gene: an early marker of neoplastic progression in ulcerative colitis Gastroenterology 107 1994 369 378 (Pubitemid 24233310)
28. S.P. Hussain, P. Amstad, and K. Raja Increased p53 mutation load in noncancerous colon tissue from ulcerative colitis: a cancer-prone chronic inflammatory disease Cancer Res 60 2000 3333 3337 (Pubitemid 30482141)
29. J.P. Issa, N. Ahuja, and M. Toyota Accelerated age-related CpG island methylation in ulcerative colitis Cancer Res 61 2001 3573 3577 (Pubitemid 32694963)
30. A.S. Fleisher, M. Esteller, and N. Harpaz Microsatellite instability in inflammatory bowel disease-associated neoplastic lesions is associated with hypermethylation and diminished expression of the DNA mismatch repair gene, hMLH1 Cancer Res 60 2000 4864 4868
31. C.J. Hsieh, B. Klump, and K. Holzmann Hypermethylation of the p16INK4a promoter in colectomy specimens of patients with long-standing and extensive ulcerative colitis Cancer Res 58 1998 3942 3945 (Pubitemid 28405652)
32. F. Sato, N. Harpaz, and D. Shibata Hypermethylation of the p14(ARF) gene in ulcerative colitis-associated colorectal carcinogenesis Cancer Res 62 2002 1148 1151 (Pubitemid 34160301)
33. M.R. Kohonen-Corish, J.J. Daniel, and H. te Riele Susceptibility of Msh2-deficient mice to inflammation-associated colorectal tumors Cancer Res 62 2002 2092 2097 (Pubitemid 34408457)
34. H.S. Cooper, L. Everley, and W.C. Chang The role of mutant Apc in the development of dysplasia and cancer in the mouse model of dextran sulfate sodium-induced colitis Gastroenterology 121 2001 1407 1416 (Pubitemid 33140458)
35. N. Barker, R.A. Ridgway, and J.H. van Es Crypt stem cells as the cells-of-origin of intestinal cancer Nature 457 2009 608 612
36. W. Qiu, X. Wang, and B. Leibowitz Chemoprevention by nonsteroidal anti-inflammatory drugs eliminates oncogenic intestinal stem cells via SMAC-dependent apoptosis Proc Natl Acad Sci U S A 107 2010 20027 20032
37. A. Shaker, and D.C. Rubin Intestinal stem cells and epithelial- mesenchymal interactions in the crypt and stem cell niche Transl Res 156 2010 180 187
38. A. Shaker, E.A. Swietlicki, and L. Wang Epimorphin deletion protects mice from inflammation-induced colon carcinogenesis and alters stem cell niche myofibroblast secretion J Clin Invest 120 2010 2081 2093
39. S.P. Hussain, L.J. Hofseth, and C.C. Harris Radical causes of cancer Nature Rev Cancer 276 2003 276 285 (Pubitemid 37328863)
40. R.J. Xavier, and D.K. Podolsky Unravelling the pathogenesis of inflammatory bowel disease Nature 448 2007 427 434 (Pubitemid 47123518)
41. L.J. Hofseth, S. Saito, and S.P. Hussain Nitric oxide-induced cellular stress and p53 activation in chronic inflammation Proc Natl Acad Sci U S A 100 2003 143 148 (Pubitemid 36078042)
42. H. Kimura, R. Hokari, and S. Miura Increased expression of an inducible isoform of nitric oxide synthase and the formation of peroxynitrite in colonic mucosa of patients with active ulcerative colitis Gut 42 1998 180 187 (Pubitemid 28212172)
43. D. Rachmilewitz, J.S. Stamler, and D. Bachwich Enhanced colonic nitric oxide generation and nitric oxide synthase activity in ulcerative colitis and Crohn's disease Gut 36 1995 718 723
44. S.J. McKenzie, M.S. Baker, and G.D. Buffinton Evidence of oxidant-induced injury to epithelial cells during inflammatory bowel disease J Clin Invest 98 1996 136 141 (Pubitemid 26243829)
45. R. D'Inca, R. Cardin, and L. Benazzato Oxidative DNA damage in the mucosa of ulcerative colitis increases with disease duration and dysplasia Inflamm Bowel Dis 10 2004 23 27 (Pubitemid 38072441)
46. L.J. Marnett Oxyradicals and DNA damage Carcinogenesis 21 2000 361 370 (Pubitemid 30137921)
47. C.L. Chang, G. Marra, and D.P. Chauhan Oxidative stress inactivates the human DNA mismatch repair system Am J Physiol Cell Physiol 283 2002 C148 C154
48. T.A. Brentnall, D.A. Crispin, and M.P. Bronner Microsatellite instability in nonneoplastic mucosa from patients with chronic ulcerative colitis Cancer Res 56 1996 1237 1240 (Pubitemid 26080961)
49. A. Noffsinger, S. Kretschmer, and J. Belli Microsatellite instability is uncommon in intestinal mucosa of patients with Crohn's disease Dig Dis Sci 45 2000 378 384 (Pubitemid 30133902)
50. D. Rachmilewitz, J.S. Stamler, and F. Karmeli Peroxynitrite-induced rat colitisa new model of colonic inflammation Gastroenterology 105 1993 1681 1688 (Pubitemid 24002783)
51. D.N. Seril, J. Liao, and G.Y. Yang Oxidative stress and ulcerative colitis-associated carcinogenesis: studies in humans and animal models Carcinogenesis 24 2003 353 362 (Pubitemid 36432628)
52. R. Hokari, S. Kato, and K. Matsuzaki Reduced sensitivity of inducible nitric oxide synthase-deficient mice to chronic colitis Free Radic Biol Med 31 2001 153 163 (Pubitemid 32607582)
53. B. Ahn, and H. Ohshima Suppression of intestinal polyposis in Apc(Min/+) mice by inhibiting nitric oxide production Cancer Res 61 2001 8357 8360 (Pubitemid 33131104)
54. S.R. Ritland, J.A. Leighton, and Hirsch Evaluation of 5-aminosalicylic acid (5-ASA) for cancer chemoprevention: lack of efficacy against nascent adenomatous polyps in the Apc(Min) mouse Clin Cancer Res 5 1999 855 863 (Pubitemid 29180838)
55. F.F. Chu, R.S. Esworthy, and P.G. Chu Bacteria-induced intestinal cancer in mice with disrupted Gpx1 and Gpx2 genes Cancer Res 64 2004 962 968 (Pubitemid 38176898)
56. B.K. Popivanova, K. Kitamura, and Y. Wu Blocking TNF-a in mice reduces colorectal carcinogenesis associated with chronic colitis J Clin Invest 118 2008 560 570 (Pubitemid 351206546)
57. T. Poutahidis, K.M. Haigis, and V.P. Rao Rapid reversal of interleukin-6-dependent epithelial invastion in a mouse model of microbially induced colon carcinoma Carcinogenesis 28 2007 2614 2623 (Pubitemid 350238965)
58. Y.J. Kim, K.S. Hong, and J.W. Chung Prevention of colitis-associated carcinogenesis with infliximab Cancer Prev Res 3 2010 1314 1333
59. G. Rogler, K. Brand, and D. Vogl Nuclear factor kappaB is activated in macrophages and epithelial cells of inflamed intestinal mucosa Gastroenterology 115 1998 357 369 (Pubitemid 28363428)
60. F.R. Greten, L. Eckmann, and T.F. Greten IKKb links inflammation and tumorigenesis in a mouse model of colitis-associated cancer Cell 118 2004 285 296 (Pubitemid 39061110)
61. A. Paradisi, C. Maisse, and M.M. Coissieux Netrin-1 up-regulation in inflammatory bowel diseases is required for colorectal cancer progression PNAS 106 2009 17146 17151
62. K.A. Baltgavis, F.G. Berger, and M.M. Pena Interleukin-6 and cachexia in APCMin/+ mice Am J Physiol Regul Integr Comp Physiol 294 2008 R393 R401
63. Y.C. Chung, and Y.F. Chang Serum interleukin-6 levels reflect the disease status of colorectal cancer J Surg Oncol 83 2003 222 226
64. C. Becker, M.C. Fantini, and C. Schramm TGF-b suppresses tumor progression in colon cancer by inhibition of IL-6 trans-signaling Immunity 21 2004 491 501 (Pubitemid 39370505)
65. S. Grivennikov, and E.Terzic Karin IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer Cancer Cell 15 2009 103 113
66. Y. Li, C. de Haar, and M. Chen Disease-related expression of the IL6/STAT3/SOCS3 signalling pathway in ulcerative colitis and ulcerative colitis-related carcinogenesis Gut 59 2010 227 235
67. J. Bollrath, T.J. Phesse, and V.A. von Burstin gp130-mediated Stat3 activation in enterocytes regulates cell survival and cell-cycle progression during colitis-associated tumorigenesis Cancer Cell 15 2009 91 102
68. L. Deng, J.F. Zhou, and R.S. Sellers A novel mouse model of inflammatory bowel disease links mammalian target of rapamycin-dependent hyperproliferation of colonic epithelium to inflammation-associated tumorigenesis Am J Pathol 176 2010 952 967
69. S. Wu, K.J. Rhee, and E. Albesiano A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses Nat Med 15 2009 1016 1023
70. W.S. Garrett, S. Punit, and C.A. Gallini Colitis-associated colorectal cancer driven by T-bet deficiency in dendritic cells Cancer Cell 116 2009 208 219
71. F. Pages, A. Berger, and M. Camus Effector memory T cells, early metastasis, and survival in colorectal cancer N Engl J Med 353 2005 2654 2666 (Pubitemid 41817714)
72. S.E. Erdman, and T. Poutahidis Roles for inflammation and regulatory T cells in colon cancer Toxicologic Pathol 38 2010 76 87
73. K.W. Moore, R. de Waal Malefyt, and R.L. Coffman Interleukin-10 and the interleukin-10 receptor Annu Rev Immunol 19 2001 683 765 (Pubitemid 32368050)
74. D.J. Berg, N. Davidson, and R. Kuhn Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses J Clin Invest 98 1996 1010 1020 (Pubitemid 26293320)
75. L. O'Mahony, M. Feeney, and S. O'Halloran Probiotic impact on microbial flora, inflammation and tumour development in IL-10 knockout mice Aliment Pharmacol Ther 15 2001 1219 1225 (Pubitemid 32675457)
76. E. Balish, and T. Warner Enterococcus faecalis induces inflammatory bowel disease in interleukin-10 knockout mice Am J Pathol 160 2002 2253 2257 (Pubitemid 34663415)
77. S. Kado, K. Uchida, and H. Funabashi Intestinal microflora are necessary for development of spontaneous adenocarcinoma of the large intestine in T-cell receptor beta chain and p53 double-knockout mice Cancer Res 61 2001 2395 2398 (Pubitemid 32685812)
78. S.E. Erdman, T. Poutahidis, and M. Tomczak CD4+ CD25+ regulatory T lymphocytes inhibit microbially induced colon cancer in Rag2-deficient mice Am J Pathol 162 2003 691 702 (Pubitemid 36267876)
79. S.E. Erdman, V.P. Rao, and T. Poutahidis CD4(+)CD25(+) regulatory lymphocytes require interleukin 10 to interrupt colon carcinogenesis in mice Cancer Res 63 2003 6042 6050 (Pubitemid 37187508)
80. S. Rakoff-Nahoum, and R. Medzhitov Toll-like receptors and cancer Nature Rev 9 2009 57 63
81. J. Terzic, S. Grivennikov, and E. Karin Inflammation and colon cancer Gastroenterology 138 2010 2101 2114
82. S.W. Kim, H.M. Kim, and K.M. Yang Bifidobacterium lactis inhibits NF-kB in intestinal epithelial cells and prevents acute colitis and colits-associated colon cancer in mice Inflamm Bowel Dis 16 2010 1514 1525
83. M. Fukata, and M.T. Abreu Pathogen recognition receptors, cancer and inflammation in the gut Curr Opin Pharmacol 9 2009 680 687
84. M. Fukata, A. Chen, and A.S. Vamadevan Toll-like receptor-4 promotes the development of colitis-associated colorectal tumors Gastroenterology 133 2007 1869 1881
85. J.M. Uronis, M. Muhlbauer, and H.H. Herfarth Modulation of the intestinal microbiota alters colitis-associated colorectal cancer susceptibility PLoS One 4 2009 e6026
86. B.K. Popivanova, F.I. Kostadinova, and K. Furuichi Blockade of chemokine, CCL2, reduces chronic colitis-associated carcinogenesis in mice Cancer Res 69 2009 7884 7892
87. G. Bongers, D. Maussang, and L.R. Muniz The cytomegalovirus-encoded chemokine receptor US28 promotes intestinal neoplasia in transgenic mice J Clin Invest 120 2010 3969 3978